Related Experiment Video
Updated: Jul 19, 2026
12:18
Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
Published on: February 9, 2011
First case of Staphylococcus pseudintermedius infection in a human
Lieve Van Hoovels1, Anne Vankeerberghen, An Boel
1Department of Clinical Microbiology, OLV Hospital, Moorselbaan 164, B-9300 Aalst, Belgium.
Journal of Clinical Microbiology
|October 20, 2006
Summary
This report details the first human Staphylococcus pseudintermedius infection. Accurate identification requires both phenotypic and genotypic tests, as it can be mistaken for Staphylococcus aureus.
Area of Science:
- Microbiology
- Infectious Diseases
- Clinical Medicine
Background:
- Staphylococcus aureus is a common human pathogen.
- Staphylococcus pseudintermedius is a common pathogen in companion animals.
- Distinguishing between these species is crucial for appropriate treatment.
Observation:
- A human patient presented with a Staphylococcus pseudintermedius infection.
- Biochemical tests alone may lead to misidentification as S. aureus.
- Microscopic and biochemical characteristics can be similar between S. pseudintermedius and S. aureus.
Findings:
- This is the first reported case of S. pseudintermedius infection in a human.
- Accurate species identification necessitates a combination of phenotypic and genotypic methods.
- Genotypic analysis confirmed the isolate as S. pseudintermedius, not S. aureus.
Implications:
- Clinicians and microbiologists must be aware of this potential pathogen in human infections.
- Misidentification could lead to inappropriate antimicrobial therapy.
- Enhanced diagnostic strategies are needed to differentiate S. pseudintermedius from S. aureus in clinical settings.
Related Concept Videos
01:29Staphylococcal Skin Infections
Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:26Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...